127 related articles for article (PubMed ID: 1668679)
1. Multiple antigen peptides (MAPs) as candidate vaccines against malaria.
Pessi A; Bianchi E; Chiappinelli L; Bonelli F; Tougne C; Lambert PH; Del Giudice G
Parassitologia; 1991 Apr; 33(1):79-84. PubMed ID: 1668679
[TBL] [Abstract][Full Text] [Related]
2. A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes.
Del Giudice G; Tougne C; Louis JA; Lambert PH; Bianchi E; Bonelli F; Chiappinelli L; Pessi A
Eur J Immunol; 1990 Jul; 20(7):1619-22. PubMed ID: 2201549
[TBL] [Abstract][Full Text] [Related]
3. Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide.
Pessi A; Valmori D; Migliorini P; Tougne C; Bianchi E; Lambert PH; Corradin G; Del Giudice G
Eur J Immunol; 1991 Sep; 21(9):2273-6. PubMed ID: 1889465
[TBL] [Abstract][Full Text] [Related]
4. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
Rzepczyk CM; Csurhes PA; Lord R; Matile H
J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
[TBL] [Abstract][Full Text] [Related]
5. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
[TBL] [Abstract][Full Text] [Related]
6. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.
Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH
J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341
[TBL] [Abstract][Full Text] [Related]
7. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.
Good MF; Branigan J; Smith G; Houghten RA
Pept Res; 1990; 3(3):110-5. PubMed ID: 1724615
[TBL] [Abstract][Full Text] [Related]
8. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
Koski GK; Ploton IN; Viscidi R; Kumar N
Pept Res; 1996; 9(3):127-35. PubMed ID: 8875592
[TBL] [Abstract][Full Text] [Related]
9. [Use of synthetic carriers and adjuvants for increasing the immunogenicity of a synthetic peptide from the CS-protein of Plasmodium falciparum].
Ivanov BB; Meshcheriakova EA; Andronova TM; Ivanov VT
Bioorg Khim; 1991 Jun; 17(6):732-46. PubMed ID: 1723268
[TBL] [Abstract][Full Text] [Related]
10. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
11. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
[TBL] [Abstract][Full Text] [Related]
12. Class II restriction in mice to the malaria candidate vaccine ring infected erythrocyte surface antigen (RESA) as synthetic peptides or as expressed in recombinant vaccinia.
Lew AM; Langford CJ; Pye D; Edwards S; Corcoran L; Anders RF
J Immunol; 1989 Jun; 142(11):4012-6. PubMed ID: 2715642
[TBL] [Abstract][Full Text] [Related]
13. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
Franke ED; Corradin G; Hoffman SL
J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
[TBL] [Abstract][Full Text] [Related]
14. Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2.
Saul A; Lord R; Jones GL; Spencer L
J Immunol; 1992 Jan; 148(1):208-11. PubMed ID: 1727867
[TBL] [Abstract][Full Text] [Related]
15. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
16. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
Amante FH; Crewther PE; Anders RF; Good MF
J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
[TBL] [Abstract][Full Text] [Related]
17. Identification and evaluation of universal epitopes in Plasmodium vivax Duffy binding protein.
Saravia C; Martinez P; Granados DS; Lopez C; Reyes C; Patarroyo MA
Biochem Biophys Res Commun; 2008 Dec; 377(4):1279-83. PubMed ID: 19000655
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
[TBL] [Abstract][Full Text] [Related]
20. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
